CENTRAL NERVOUS SYSTEM ABSCESS

CENTRAL NERVOUS SYSTEM ABSCESS was reported 46 times

CENTRAL NERVOUS SYSTEM ABSCESS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antimetabolite Immunosuppressant [EPC] 13 0.0006
1 CD52-directed Cytolytic Antibody [EPC] 6 0.0003
2 CD38-directed Cytolytic Antibody [EPC] 1 0.0002
3 Echinocandin Antifungal [EPC] 1 0.0001
4 Lipid-based Polyene Antifungal [EPC] 1 0.0001
5 Bile Acid [EPC] 1 0.0000
6 Penem Antibacterial [EPC] 1 0.0000
7 Interleukin-17A Antagonist [EPC] 1 0.0000
8 Cholinergic Muscarinic Antagonist [EPC] 1 0.0000
9 Polyene Antifungal [EPC] 1 0.0000
10 Antirheumatic Agent [EPC] 2 0.0000
11 Corticosteroid [EPC] 23 0.0000
12 Complement Inhibitor [EPC] 1 0.0000
13 Alkylating Drug [EPC] 4 0.0000
14 Calcineurin Inhibitor Immunosuppressant [EPC] 2 0.0000
15 Nitroimidazole Antimicrobial [EPC] 1 0.0000
16 Cardiac Glycoside [EPC] 1 0.0000
17 Platinum-based Drug [EPC] 3 0.0000
18 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
19 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
20 Purine Antimetabolite [EPC] 1 0.0000
21 Aromatase Inhibitor [EPC] 1 0.0000
22 Proteasome Inhibitor [EPC] 1 0.0000
23 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
24 Opioid Agonist [EPC] 2 0.0000
25 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
26 Calcium [EPC] 1 0.0000
27 Azole Antifungal [EPC] 1 0.0000
28 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
29 RANK Ligand Inhibitor [EPC] 1 0.0000
30 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
31 Insulin Analog [EPC] 2 0.0000
32 Thalidomide Analog [EPC] 2 0.0000
33 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
34 Vitamin D [EPC] 1 0.0000
35 Vitamin B12 [EPC] 1 0.0000
36 Vitamin C [EPC] 1 0.0000
37 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
38 Kinase Inhibitor [EPC] 1 0.0000
39 Platelet Aggregation Inhibitor [EPC] 1 0.0000
40 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000
41 Benzodiazepine [EPC] 1 0.0000